drugset / Trial / NCT03794505

Quality of Life and Pain With Infiltration or Suprascapular Nerve Block in Glenohumeral Arthirtis

NCT03794505

Phase 3 Completed 40 enrolled Mexican Social Security Institute
RandomizedParallel-groupDouble-blindTreatment

Summary

Efficacy in pain and health related quality of life of suprascapular nerve block ultrasound guided and glenohumeral infiltration in glenohumeral arthritis

Timeline

Start
2018-04-01
Primary completion
2018-08-30
Completion
2018-08-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Lidocaine Other / unclassified 2 ml Other
Comparator Lidocaine Other / unclassified 2 % Other
Background Methylprednisolone Other / unclassified 40 mg Other
Background Ropivacaine Other / unclassified 25 mg Other

Indications

No indication recorded.